ARS Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ARS Pharmaceuticals generated cash of -$59,266,000, which is less than the previous year. Cash used in financing activities reached the amount of $6,899,000 last year. Net change in cash is therefore -$139,547,000.
Cash Flow
| 2019 | -18.89M | -96K | 8.61M |
|---|---|---|---|
| 2020 | 9.07M | -917K | 5.09M |
| 2021 | -17.56M | -55K | 53.15M |
| 2022 | -40.07M | -199K | 190.73M |
| 2023 | -59.26M | -87.18M | 6.89M |
SPRY Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 210.51M | 60.06M | 24.52M | 10.35M | 20.16M |
Operating activities | |||||
Net income | -54.36M | -34.68M | -20.24M | -1.06M | -23.96M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 73K | 319K | 6K | 6K | 1.54M |
Stock-based compensation expense | 9.23M | 5.84M | 2.82M | 3.54M | 0 |
| Deferred income tax benefit | 9.23M | 5.84M | 2.82M | 3.54M | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -2.77M | -10.28M | 6.03M | 1.79M | 4.01M |
Cash generated by operating activities | -59.26M | -40.07M | -17.56M | 9.07M | -18.89M |
Investing activities | |||||
Purchases Of Investments | -272.00M | 0 | -65.10M | 0 | 0 |
Investments In Property Plant And Equipment | -175K | -199K | -55K | -917K | -96K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -87.18M | -199K | -55K | -917K | -96K |
Financing activities | |||||
Common Stock Issued | 6.89M | 570K | 54.97M | 409.20M | 19K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -8.68M | -1.81M | -700K | 8.59M |
Cash used in financing activities | 6.89M | 190.73M | 53.15M | 5.09M | 8.61M |
Net Change In Cash | -139.54M | 150.45M | 35.54M | 14.17M | -10.18M |
Cash at end of period | 70.97M | 210.51M | 60.06M | 24.52M | 9.97M |
| Data source | Data source | Data source |